TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in expression of transcription factors and antioxidant enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intestinal microbiota profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Neck-Disability-Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck-pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Tolerated Dose (MTD)/Coverage with evidence development (CED)/recommended phase 2 dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Icapamespib Plasma Concentration at Time of Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of plasma exchanges required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Brief Fatigue Inventory (BFI) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Short Form Health Survey (SF-12) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall acceptability of entire interactive virtual educational program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: WHO-5 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Hamilton Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Finger Stick BHB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of subcutaneous and/or sub-rectus hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of intra-abdominal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Need for abdominal re-exploration or wound hematoma evacuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for any other intervention e.g. redo valve replacement surgery in case of a stuck valve
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of a valve thrombosis or other thromboembolic manifestations e.g. stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of alcohol withdrawal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PvCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety inventory score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in resting-state functional connectivity (RSFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in hemoglobin signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Tinnitus Severity Grading
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of treatment emergent adverse events leading to study drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment emergent >/= Grade 3 clinical laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinically significant changes from baseline in hematology and clinical chemistry laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Adaptive Behavior Assessment System (ABAS-3)
Endpoint domain: Life impact
Endpoint subdomain: Functional outcomes
Primary endpoint: TOPSE: Tool to measure Parenting Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: KCCQ (Kansas City Cardiomyopathy Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lymph node retrieval rate marked
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Number of sentinel and marked lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Concordance between marked and sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Rate of acute graft-versus-host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Intestinal blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Renal blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Listening rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduced generalized anxiety disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fatigue Severity Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Clinical Postoperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with mRS score 0-3 at 90 days post-stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate in the Cerebrolysin group
Endpoint domain: Mortality/survival
Primary endpoint: 6-minute-walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 year overall survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in Hamilton Anxiety (HAMA) scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in self-rating anxiety scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in activity of daily living (ADL) scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Measurement of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculation of body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of total body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multiple Sclerosis Impact Scale (MSIS-29)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reports of the prescribing of adult ADHD medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incontinence symptoms and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep quality (Pittsburgh Sleep Quality Index-PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fear of falling-Fall Efficacy Scale (FES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neuropeptide Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Completed Interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Coping Attitudes Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional Skills And Competence Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Questionnaire on Resources And Stress-F
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Occurrence of adverse events related to study procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Score acne (acne grading system by Cremoncini et al)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Score hirsutism (Ferriman-Gallwey score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration up to the last measurable concentration (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time 0 to infinite (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle activity (microVolts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total standardized muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune cell phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune cell gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average test score difference before and after training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increasing mothers' breastfeeding self-efficacy scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increasing Latch breastfeeding scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding on Probing (BOP) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to stable culture conversion in liquid media
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants experiencing any Grade 3 or higher adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Complications during RIRS procedure
Endpoint domain: Adverse events/effects
Primary endpoint: PLD-Q at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Full mouth plaque score (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to achieve successful Endotracheal Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time taken to achieve the best possible view of the glottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: No. of Intubation attempts needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants with symptomatic intracerebral hemorrhage (sICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Dichotomized good functional outcome (mRS 0-2)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Left/right judgement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination of acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematologic very good partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Completion of exercise sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ankle plantar-flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Vibrational Frequency of Vocalization Following Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Temperature of the Surgical Site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular Force Generated During Range of Motion Exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of clinical characteristics of patients with cardiogenic shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: In-hospital clinical evolution of patients with cardiogenic shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of complications in patients with cardiogenic shock
Endpoint domain: Adverse events/effects
Primary endpoint: Score for smear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of vaginitis type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in TEI/TEE ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of delayed cerebral ischemia lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: One-year probability of overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Time to complete preparation and administration of the glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of glucagon administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: curative effect of breast cancer surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: changes in PD (pocket depth in millimetres)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in CAL (clinical attachment level in millimetres)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in microbiome (rt PCR test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum and urinary catecholamine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in fecal bacterial abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in fecal microbial diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in fecal microbial composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with status epilepticus termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: occurrence rate of postoperative atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean AUC of Betahistine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugyl Meyer Assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nurses' perceptions about patient safety culture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in brain-derived neurotrophic factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in cerebrovascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nicotine and cotinine serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity and cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prealbumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of plasma level of Interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of hypertensive disorders of pregnancy (HDP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of large for gestational age (LGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Average VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement of subcutaneous heparin applications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: strehl ratio (SR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modulation transfer function cutoff frequency (MTF cutoff)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objective scatter index (OSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse event (dose limited toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of radiation pneumonia ≥ grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: Total Amount of Time Spent Per User on All Courses Combined
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Percentage of Participants Who Completed All Courses
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Periodic Limb Movement Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in mindset about the Process of Health - Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful procurement of a viable uterus for transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Score of II or less on the Clavian-Dindo Scale
Endpoint domain: Adverse events/effects
Primary endpoint: Successful transplantation of a human uterus with achievement of menstrual cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Successful establishment of a pregnancy via in vitro fertilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Successful live birth
Endpoint domain: Mortality/survival
Primary endpoint: Change in FFR value before and after TAVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in FFR value before and after TMVr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax,ss of RLD2202
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCtau,ss of RLD2202
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cmax,ss of RLD2203
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCtau,ss of RLD2203
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Inhibition of Platelet Aggregation(%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in verbal fluency task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in intention to use of e-cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total requirement dose of rescue analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible patients receiving VTE prophylaxis prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients adherent to pharmacologic extended VTE prophylaxis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: changes of daily activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: changes of attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum interleukin (IL)-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum lipopolysaccharide binding protein (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum tumor necrosis factor (TNF)-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in actigraphy sleep latency onset
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cord arterial partial pressure of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord arterial partial pressure of carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord venous pH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord venous partial pressure of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord venous partial pressure of carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peptidoglycan fragment content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binge/purge episodes trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perfusion in heart, brain and kidneys
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Definite COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Probable COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Readmission/urgent outpatient visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Faecal IgA levels as a marker for NEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ART uptake and first refill within 60 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documented HIV viral load <50 copies/mL at 6-10 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes